Protocol of a monocentric, double-blind, randomized, superiority, controlled trial evaluating the effect of in-prison OROS-methylphenidate vs. placebo treatment in detained people with attention-deficit hyperactivity disorder (BATIR).
Journal Information
Full Title: Trials
Abbreviation: Trials
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateThe Geneva’ cantonal ethics committee approved the study protocol (no. 2022-02207). The study will be conducted in accordance to the Declaration of Helsinki. Oral and written informed consent to participate will be obtained from all participants. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."
"Funding This study was supported by the Swiss National Science Foundation (grant no. 212581)."
"Trial registration ClinicalTrials.govNCT05842330. Registered on June 5, 2023. Kofam.ch SNCTP000005388. Registered on July 17, 2023."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025